Related Experiment Videos
Phenotypically distinct B cell development pathways map to the three B cell lineages in the mouse
James W Tung1, Matthew D Mrazek, Yang Yang
1Department of Genetics, Stanford School of Medicine, Stanford University, Stanford, CA 94305-5318, USA.
Summary
New markers, syndecan-1 (CD138) and MHC class II (I-A), distinguish neonatal and adult B cell development pathways. CD138 expression identifies distinct early B cell progenitors, clarifying B cell lineage development.
Area of Science:
- Immunology
- Developmental Biology
- Cell Biology
Background:
- B cell development pathways differ significantly between neonates and adults.
- Early B cell progenitors for B-1 and B-2 cells have been previously distinguished.
- Identifying specific markers for these distinct progenitor populations remains crucial.
Purpose of the Study:
- To introduce syndecan-1 (CD138) and MHC class II (I-A) as novel markers for early B cell development.
- To differentiate neonatal and adult predominant B cell development pathways using these markers.
- To further characterize B cell progenitor populations and their lineage commitment.
Main Methods:
- Analysis of syndecan-1 (CD138) and MHC class II (I-A) expression on pre-B cells from neonatal and adult mice.
- Flow cytometry and cell sorting to isolate specific progenitor populations.
- In vitro differentiation assays to assess the maturation potential of sorted progenitor cells.
Main Results:
- Neonatal and adult predominant pre-B cells differ in CD138 and I-A expression.
- Adult pre-B cells (Hardy fraction D) express high CD138 and intermediate I-A.
- Neonatal pre-B cells predominantly lack CD138 and I-A expression but mature to IgM+ B cells.
Conclusions:
- Syndecan-1 (CD138) and MHC class II (I-A) expression effectively distinguish neonatal from adult B cell development pathways.
- CD138 expression further subdivides adult B cell progenitor populations, consistent with B-1b progenitor predominance.
- These markers provide a key method for distinguishing early B cell development pathways across three distinct B cell lineages.